ट्रेड Novavax NVAX

बेचें
 खरीदें

Novavax लाइव चार्ट

5m 15m 30m 1h 4h 1d 1w

उपकरण मूल बातें

Weekly Search
Weekly
Daily
दिनांक बंद करें परिवर्तन (%) परिवर्तित करें खुला उच्च कम

Novavax news

2021 मई 11, 13:20

US pre-market: selling unabated

2021 मई 06, 08:27

Stocks rally as Fed speakers get back on script, earnings support + Bank of England set to raise forecasts

2021 Feb 28, 07:36

Week Ahead: RBA speaks, US NFPs released & OPEC clash

2020 मई 26, 08:04

Leg up: stocks make new ground, travel stocks soar

नवीनतम समाचार

और दिखाएं
Noah Lee 2025 Sep 15, 13:20

Musk's Tesla Stock Purchase Fuels Confidence, Sends Shares Soaring

Liam James 2025 Sep 15, 13:20

Trump Proposes Semiannual Reporting for US Companies: Cost Savings or Reduced Transparency?

Ava Grace 2025 Sep 15, 12:20

Russia Tests Zircon Missile, Drills with Belarus; US Observes Amid Geopolitical Maneuvering

Ava Grace 2025 Sep 15, 11:20

Fed Rate Hike Outlook 2025: Inflation and Jobs Market in Focus

Emma Rose 2025 Sep 15, 10:20

India Gold Demand Forecast to Weaken During Festival Season Due to High Prices

Noah Lee 2025 Sep 15, 09:20

Fed Rate Cut Outlook Amid Sticky Inflation and Labor Market Signals

Emma Rose 2025 Sep 15, 09:20

US Job Market Slowdown: Trade Turmoil's Impact and Future Outlook

Ava Grace 2025 Sep 15, 09:20

Russian Drone Enters Romanian Airspace: NATO Response and Escalating Tensions

जानकारी

स्प्रेड

0.06

स्प्रेड (%)

0.7491 %

लीवरेज

1:10

ओवरनाइट ब्याज विक्रय

-0.0597 %

overnight_interest_sell

-0.0292 %

मुद्रा

USD

ट्रेडिंग घंटे

बाज़ार खुला है

सोमवार

13:31 - 19:59

मंगवार

13:31-19:59

बुधवार

13:31-19:59

गुरुवार

13:31-19:59

शुक्रवार

13:31-19:59

विश्लेषण और सांख्यिकी

खुला

---

पिछला बंद

---

52 सप्ताह उच्च/निम्न्च

--- – ---

बाज़ार आकार

1296127616

बकाया शेयर

162422000

प्राप्ति की तिथि (आगे)

2019-05-10

लाभांश आय 

2019-05-10

पूर्व-लाभांश तिथि

अग्रिम वार्षिक लाभांश दर 

0

अग्रिम वार्षिक लाभांश आय

0

EPS

2.22

इस उपकरण के बारे में अधिक जानें

Novavax Novavax Inc
Novavax, Inc., a biotechnology company, engages in the discovering, developing, and commercializing vaccines to protect against serious infectious diseases in the United States, Europe, and internationally. The company offers vaccine platform that combines a recombinant protein approach, nanoparticle technology, and its patented Matrix-M adjuvant to enhance the immune response. The company is commercializing a COVID-19 vaccine, NVX-CoV2373 under the brand names of Nuvaxovid, Covovax, and Novavax COVID-19 Vaccine, adjuvanted for adult and adolescent populations as a primary series and for both homologous and heterologous booster indications. It also developing R21/Matrix-M adjuvant malaria vaccine. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.

संबंधित उपकरण

संपत्ति
बेचें
खरीदें
(%) परिवर्तित करें

अब ट्रेड करें

अब ट्रेड करें

अब ट्रेड करें

अब ट्रेड करें
view_all_instruments

latest_education_articles

और दिखाएं
Trustpilot